Business News
The Veteran Pharma Founders That Keep Buying Their Own NASDAQ Stock
Nuvectis Pharma CEO Ron Bentsur, a veteran in the pharma industry, has invested over $3 million into the company. Bentsur: "Our continued investment in Nuvectis reflects our unwavering belief in the transformative potential of our pipeline"